Blog

Bristol-Myers to invest in Dutch gene therapy company uniQure

(Reuters) – Bristol-Myers Squibb Co said it would invest in Dutch biotech uniQure NV, joining other big drugmakers who have moved to gain a foothold in the promising gene therapy market. UniQure’s shares jumped more than 55 percent on Monday after Bristol-Myers said it would pick up a 4.9 percent stake in the company. UniQure’s gene therapy drug, Glyberan, went on sale last year priced at 1.1 million euros. Investor